Medical oncology
511 – 525 of 534
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1996
-
Mark
Novel germline p16 mutation in familial malignant melanoma in southern Sweden
(
- Contribution to journal › Article
-
Mark
Blood transfusion as a risk factor for non-Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors
(
- Contribution to journal › Article
-
Mark
Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases
(
- Contribution to journal › Article
-
Mark
Reproducibility of a self-administered questionnaire for assessment of melanoma risk
(
- Contribution to journal › Article
-
Mark
Risk of cancer in relatives of testicular cancer patients
(
- Contribution to journal › Article
-
Mark
Familial testicular cancer in Norway and southern Sweden
(
- Contribution to journal › Article
-
Mark
Genetic predisposition to breast cancer
(
- Contribution to journal › Article
-
Mark
Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group
(
- Contribution to journal › Article
-
Mark
Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus
(
- Contribution to journal › Article
- 1995
-
Mark
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
(
- Contribution to journal › Article
-
Mark
Is the use of sunscreens a risk factor for malignant melanoma?
(
- Contribution to journal › Article
-
Mark
The Sarcoma Group
(
- Contribution to journal › Article
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article
- 1994
-
Mark
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
(
- Contribution to journal › Article